• 1
    National Committee for Quality Assurance 2008 The state of health care quality. Available at . Accessed January 19, 2009.
  • 2
    Siris ES, Chen Y-T, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML 2004 Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164: 11081112.
  • 3
    Schuit SCE, Van der Klift M, Weel AEM, De Laet CEDH, Burger H, Seeman E, Hofman A, Uitterlinden AG, van Leeuwen JPTM, Pols HAP 2004 Fracture incidence and association with bone mineral density in men and women: The Rotterdam Study. Bone 34: 195202.
  • 4
    Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD 2005 Identification of osteopenic women at high risk of fracture: The OFELY study. J Bone Miner Res 20: 18131819.
  • 5
    Robbins J, Aragaki AK, Kooperberg C, Watts N, Wactawski-Wende J, Jackson RD, LeBoff MS, Lewis CE, Chen Z, Stefanick ML, Cauley J 2007 Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA 298: 23892398.
  • 6
    Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, Johnell O 2001 An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12: 519528.
  • 7
    Kanis JA, on behalf of the World Health Organization Scientific Group 2007 Assessment of Osteoporosis at the Primary Health-Care Level. Technical Report. WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
  • 8
    Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Oglesby A 2002 International variations in hip fracture probabilities: Implications for risk assessment. J Bone Miner Res 17: 12371244.
  • 9
    Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B 2000 Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11: 669674.
  • 10
    Melton LJ III , Crowson CS, O'Fallon MW 1999 Fracture incidence in Olmstead County, Minnesota: Comparison of urban with rural rates and change in urban rates over time. Osteoporos Int 9: 2937.
  • 11
    Melton LJ III , Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Liebson CL 2009 Secular trends in hip fracture incidence and recurrence. Osteoporos Int 20: 687694.
  • 12
    Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, Luckey M 2002 Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87: 44314437.
  • 13
    Haden ST, Fuleihan GE, Angell JE, Cotran NM, LeBoff MS 1999 Calcidiol and PTH levels in women attending an osteoporosis program. Calcif Tissue Int 64: 275279.
  • 14
    Ettinger B 2008 A personal perspective on fracture risk assessment tools. Menopause 15: 10231026.
  • 15
    National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation, Washington, DC, USA.
  • 16
    Apter AJ, Paasche-Orlow MK, Remillard JT, Bennett IM, Ben-Joseph EP, Batista RM, Hyde J, Rudd RE 2008 Numeracy and communication with patients: They are counting on us. J Gen Intern Med 23: 21172124.
  • 17
    Ensrud KE, Lui L, Taylor B, Schousboe J, Donaldson M, Fink H, Cauley J, Hillier T, Browner W, Black D, Cummings S 2008 A comparison of prediction models for hip, osteoporotic and any clinical fracture in older women: Is more better ? J Bone Miner Res 23: S18.